Open Ankle Fractures: What Predicts Infection? A Multicenter Study.


Journal

Journal of orthopaedic trauma
ISSN: 1531-2291
Titre abrégé: J Orthop Trauma
Pays: United States
ID NLM: 8807705

Informations de publication

Date de publication:
01 Jan 2022
Historique:
accepted: 11 10 2021
pubmed: 30 10 2021
medline: 28 1 2022
entrez: 29 10 2021
Statut: ppublish

Résumé

To identify the patient, injury, and treatment factors associated with an acute infection during the treatment of open ankle fractures in a large multicenter retrospective review. To evaluate the effect of infectious complications on the rates of nonunion, malunion, and loss of reduction. Multicenter retrospective review. Sixteen trauma centers. One thousand and 3 consecutive skeletally mature patients (514 men and 489 women) with open ankle fractures. Fracture-related infection (FRI) in open ankle fractures. The charts of 1003 consecutive patients were reviewed, and 712 patients (357 women and 355 men) had at least 12 weeks of clinical follow-up. Their average age was 50 years (range 16-96), and average BMI was 31; they sustained OTA/AO types 44A (12%), 44B (58%), and 44C (30%) open ankle fractures. The rate FRI rate was 15%. A multivariable regression analysis identified male sex, diabetes, smoking, immunosuppressant use, time to wound closure, and wound location as independent risk factors for infection. There were 77 cases of malunion, nonunion, loss of reduction, and/or implant failure; FRI was associated with higher rates of these complications (P = 0.01). Several patient, injury, and surgical factors were associated with FRI in the treatment of open ankle fractures. Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

Identifiants

pubmed: 34711768
doi: 10.1097/BOT.0000000000002293
pii: 00005131-202201000-00007
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-48

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors report no conflict of interest.

Références

Olerud S, Karlstrom G, Danckwardt-Lillestrom G. Treatment of open fractures of tibia and ankle. Clin Orthop Relat Res. 1978;136:212–214. Court-Brown CM, McBirnie J, Wilson G. Adult ankle fractures-an increasing problem? Acta Orthop Scand. 1998;69:1, 43–47.
Dunbar RP Jr, Gardner MJ. Initial management of open fractures. Rockwood & Green’s Fract Adults. 7th ed. 2010;283–300.
Hulsker CC, Kleinveld S, Zonnenberg CB, et al. Evidence-based treatment of open ankle fractures. Arch Orthop Trauma Surg. 2011;131:1545–1553.
Metsemakers WJ, Morgenstern M, McNally MA, et al. Fracture-related infection: a consensus on definition from an international expert group. Injury. 2018;49:505–510.
Ovaska MT, Madanat R, Honkamaa M, et al. Contemporary demographics and complications of patients treated for open ankle fractures. Injury. 2015;46:1650–1655.
Patzakis MJ, Wilkins J. Factors influencing infection rate in open fracture wounds. Clin Orthop Relat Res. 1989;243:36–40.
Obremskey W, Molina C, Collinge C, et al. Current practice in the management of open fractures among orthopaedic trauma surgeions. Part A: initial Management. A survey of orthopaedic trauma surgeons. J Orthop Trauma. 2014;28:e198–e202.
Gosselin RA, Roberts I, Gillespie WJ. Antibiotics for preventing infection in open limb fractures. Cochrane Database Syst Rev. 2004;1:CD003764.
White CB, Turner NS, Lee GC, et al. Open ankle fractures in patients with diabetes mellitus. Clin Orthop Relat Res. 2003;141:37–44.
Wukich DK, Joseph A, Ryan M, et al. Outcomes of ankle fractures in patients with uncomplicated versus complicated diabetes. Foot Ankle Int. 2011;32:120–130.
Olsen MA, Nepple JJ, Riew KD, et al. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am. 2008;90:62–69.
Blanke F, Loew S, Ferrat P, et al. Osteonecrosis of distal tibia in open dislocation fractures of the ankle. Injury. 2014;45:1659–1663.

Auteurs

Margaret E Cooke (ME)

Department of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA.

Paul Tornetta (P)

Department of Orthopaedic Surgery, Boston University, Boston, MA.

Reza Firoozabadi (R)

Department of Orthopaedic Surgery, University of Washington, Seattle, WA.

Heather Vallier (H)

Department of Orthopaedic Surgery, Metrohealth Medical Center, Cleveland, OH.

Douglas S Weinberg (DS)

Department of Orthopaedic Surgery, University of North Carolina, Chapel Hill, NC.

Timothy B Alton (TB)

Proliance Orthopedics Associates, Renton, WA.

Megan R Dillman (MR)

Department of Internal Medicine & Pediatrics, Allina Health, Eagan, MN.

Jerald R Westberg (JR)

Department of Orthopedic Surgery, Hennepin County Medical Center, Minneapolis, MN.

Andrew Schmidt (A)

Department of Orthopedic Surgery, Hennepin County Medical Center, Minneapolis, MN.

Michael Bosse (M)

Department of Orthopedic Surgery, Carolinas Medical Center, Charlotte, NC.

Daniel P Leas (DP)

Department of Orthopedic Surgery, Carolinas Medical Center, Charlotte, NC.

Michael Archdeacon (M)

Department of Orthopaedics, University of Cincinnati, Cincinnati, OH.

Rafael Kakazu (R)

Department of Orthopaedics, University of Cincinnati, Cincinnati, OH.

Ifeanyi Nzegwu (I)

Department of Orthopaedic Surgery, University of Kentucky, Lexington, KY.

Robert V OToole (RV)

Department of Orthopaedic Surgery, University of Maryland Medical System, Baltimore, MD.

Timothy G Costales (TG)

Department of Orthopaedic Surgery, University of Maryland Medical System, Baltimore, MD.

Max Coale (M)

Department of Orthopaedic Surgery, University of Washington, Seattle, WA.

Brian Mullis (B)

Department of Orthopaedic Surgery, Indiana University-Purdue University Indianapolis, Indianapolis, IN.

Rashad H Usmani (RH)

Department of Orthopaedic Surgery, University of Louisville, Louisville, KY.

Kenneth Egol (K)

Department of Orthopaedic Surgery, NYU Langone Medical Center, New York, NY.

Stephen Kottmeier (S)

Department of Orthopaedics, SUNY, Stony Brook, NY.

David Sanders (D)

London Health Science Centre, Victoria Hospital, London, Canada.

Cliff Jones (C)

Department of Orthopaedic Surgery, Dignity Health Medical Group, Phoenix, AZ.

Anna N Miller (AN)

Department of Orthopaedic Surgery, Washington University in St. Louis, Saint Louis, MO.

Daniel S Horwitz (DS)

Department of Orthopaedic Surgery, Geisinger Health System, Danville, PA.

Harish Kempegowda (H)

Department of Orthopaedic Surgery, Geisinger Health System, Danville, PA.

Saam Morshed (S)

Department of Orthopaedic Surgery, University of California at San Francisco, San Francisco, CA; and.

Tigist Belaye (T)

Department of Orthopaedic Surgery, University of California at San Francisco, San Francisco, CA; and.

David Teague (D)

Department of Orthopaedic Surgery, University of OK Health Sciences Center, Oklahoma City, OK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH